ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L)1 inhibitor resistance

Published:2020-01-01 Issue:1 Volume:9 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Orme Jacob J.¹^ORCID,Jazieh Khalid A.²³,Xie Tiancheng²,Harrington Susan²,Liu Xin²,Ball Matthew⁴,Madden Benjamin⁵,Charlesworth M. Cristine⁵,Azam Tariq U.⁶,Lucien Fabrice²⁷,Wootla Bharath⁸^ORCID,Li Yanli²³,Villasboas Jose Caetano⁹^ORCID,Mansfield Aaron S.¹^ORCID,Dronca Roxana S.¹⁰,Dong Haidong³⁷

Affiliation:

1. Division of Medical Oncology, Mayo Clinic, Rochester, MN, USA

2. Department of Urology, Mayo Clinic, Rochester, MN, USA

3. Department of Internal Medicine, Cleveland Clinic, Cleveland, OH, USA

4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA

5. Proteomics Core, Mayo Clinic, Rochester, MN, USA

6. Department of Medicine, University of Michigan, Ann Arbor, MI, USA

7. Department of Immunology, Mayo Clinic, Rochester, MN, USA

8. Center for Clinical and Translational Science, Mayo Clinic, Rochester, MN, USA

9. Division of Hematology, Mayo Clinic, Rochester, MN, USA

10. Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA

Funder

National Cancer Institute

Richard M. Schulze Family Foundation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1744980

Reference40 articles.

1. A pathology atlas of the human cancer transcriptome

2. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17

3. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival

4. ADAM 10 is associated with gastric cancer progression and prognosis of patients

5. Effects of ADAM 10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications;Biomarker Research;2024-09-02

2. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application;European Journal of Pharmacology;2024-09

3. Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies;Journal of Experimental & Clinical Cancer Research;2024-05-31

4. Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma;Lung Cancer;2024-05

5. Multi-Omics Pan-Cancer Analysis of Procollagen N-Propeptidase Gene Family of ADAMTS as Novel Biomarkers to Associate with Prognosis, Tumor Immune Microenvironment, Signaling Pathways, and Drug Sensitivities;Frontiers in Bioscience-Landmark;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3